Martin H. Huber Jr.

Sits on 2 boards. Last updated September 28, 2026

Time on boards

Boards served
2
Current seats
2
Board service
4 years
Director since
2023

4 years of board service in total across 2 boards, counting each seat separately. Longest: Syndax Pharmaceuticals Inc., 3 years.

3 years · Since 2023
6 months · Since 2026

Shareholder support

Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Feb 4, 2026 Syndax Pharmaceuticals Inc. Grant or award +24,000 — —
May 19, 2025 Syndax Pharmaceuticals Inc. Open-market purchase +5,000 $8.99 $44,950
Feb 5, 2025 Syndax Pharmaceuticals Inc. Grant or award +25,000 — —
Feb 7, 2024 Syndax Pharmaceuticals Inc. Grant or award +17,000 — —
Feb 2, 2023 Syndax Pharmaceuticals Inc. Grant or award +16,000 — —

Questions about Martin H. Huber Jr.

What boards is Martin H. Huber Jr. on?

Martin H. Huber Jr. sits on the boards of Actuate Therapeutics Inc. and Syndax Pharmaceuticals Inc.

How long has Martin H. Huber Jr. served on boards?

Our records show at least 4 years of board service across 2 boards, the earliest from 2023.

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.